ABOUT US
About Ai Wei's Creatures
-- Organ-chip application full-scene solution provider
Jiangsu Aiwei Biotechnology Co., Ltd. (AVATARGET) was established in 2021. It is an innovative technology company focusing on the research and development and production of human organ chips and life science equipment. Ai Wei's core technology has been transformed into the organ chip research team of Southeast University, and the technological achievements have been successfully applied in scientific research scenarios such as new drug research and development, precision medicine, disease modeling, and beauty safety evaluation. At present, Ai Wei has reached in-depth cooperation with well-known domestic and foreign pharmaceutical companies, many hospitals, research institutions and universities to continue to promote the application of organ chips in more medical device fields and help the rapid development of life sciences.
Big
R & D Laboratory
+
Products and Applications
%
Doctor's percentage
%
Proportion of R & D personnel
Core Team
Enterprise management and innovation technology strength coexist
Gu Zhongze
Chief Scientist
Zhao Dan
Doctor/Professor/Changjiang Scholar/National Outstanding Youth
Fellow of the American Academy of Medical and Biological Engineering, Chief Scientist of the Provincial Innovative Medical Device Industry Chain, Director of the National Key Laboratory of Digital Medical Engineering, the only Chinese director of the 16 founding directors of the International Society of Microphysiological Systems, and the Chinese Society of Biomedical Engineering Class and Organ Chip The chairman of the branch won the first prize of natural science from the Ministry of Education, and the highest prize in the National Ministry of Science and Technology Subversive Technology Competition.
Sales Manager
Working experience -12 years, case works -136 pieces of the seventh design center chief designer, loved by the majority of users, won the praise. Rich experience and the consciousness of innovation often harvest is not the same effect...
Ge Jianjun
Chairman Ai Wei
Southeast University Junior Class
Nanjing University MBA
Vice president of the top 100 private enterprises, more than 30 years of technical and management work experience, including 25 years of senior management of large and medium-sized enterprises and institutions, expert judges of the Innovation and Entrepreneurship Competition of the Department of Science and Technology and Human Resources and Social Security of Jiangsu Province, and entrepreneurial mentors of many institutions have been selected The "List of National Scientific and Technological Achievements Research and Development Heritors" awarded by the National Science and Technology Commission.
Sha Li Feng
Chief Executive Officer (CEO)
PhD, The Chinese University of Hong Kong
Previously worked in Shenzhen Meirui/Suzhou Changguanghua Medical,Nearly 20 years of IVD industry experience, presided over the development and industrialization of a variety of medical devices.,Presided over the special project of transformation of scientific and technological achievements in Jiangsu Province,Second Prize of National Science and Technology Progress Award,Second Prize of Beijing Science and Technology Progress Award,Second prize for scientific and technological progress in Suzhou.
Chen ZaoZao
Chief Technology Officer (CTO)
Southeast University Supreme Good Young Scholar/Associate Researcher
PhD in Cell Biology, University of North Carolina, USA,Postdoctoral/Associate Researcher, Duke University and Columbia University, USA,Chinese Society of Biomedical Engineering Organoids andSecretary-General of Organ Chip Branch,As a major member, more than 50 SCI/EI papers have been published in the two US organ chip 1,Il and II phases of NIH funding.,A number of national key projects and project leaders.
Vision
Become the leader of the organ chip
Mission
Care for life with "core"
Values
Seeking truth, innovation, hard work and win-win situation
Multi-line text content element
HTML language content can be parsed after rich text content is bound to data
Organ-on-a-Chip and Policy
Introduction to the Concept and Development of Organ-Chip
-Born in 2010, it is a micro-physiological system constructed in vitro
-2016, named by Davos ForumTop 10 Emerging Technologies in the World
-Build mini-human organs with biological functionality to simulate some of the functions of human organs
Patent Layout
Through the transformation of production, teaching and research and independent research and development, Ai Wei has laid out nearly 100 patents, of which 50% of the invention patent applications, patent distribution covers organ chips, biological models and materials, instruments and equipment and software and other core products. The Pre-A round of financing led by rehabilitation capital has been completed, which is nearly 100 million yuan.
As China's organ chip model standard, Ai Wei's skin chip technology has been approved by the National Standardization Management Committee.
Ava’target (Alpha Target)止于至善
The human organ chip project has successfully crossed the last kilometer from the research and development end to the application end.
Avatar'get (Avatar Get) alternative experiment
Build the whole industry chain ecosystem of organ chip technology, insight into the mystery of life science, help medical science and technology reform, and meet the individual needs of patients.
Value recognition
Since its establishment, Ai Weid's team has been selected into the list of potential unicorn companies in Jiangsu Province, and won the "First National Disruptive Technology Innovation Competition Finals Award", "First Prize of the Ninth Overseas Chinese Contribution Award", and "High-tech Zone Entrepreneurship Leading Talent Enterprise" "Second Prize of Jiangsu Information Consumption Competition", "Gusu Entrepreneurship Leading Talent Enterprise", "China Patent Excellence Award" and other awards, it has made achievements such as "China's organ chip for entering the space station and carrying out scientific experiments", "China's organ chip for applying for new drug IND" and "China's organ chip technical standards for project approval", and has completed the Pre-A round of financing of nearly 100 million yuan led by rehabilitation capital.
China's first
Organ-on-a-chip to enter the space station and perform scientific experiments
China's first
Organ-chip for application of new drug IND
China's first
Technical standard for organ-on-a-chip
Partners
Walk with you, side by side with success, we are here waiting for you to create the future together!
北京协和医院
中源生物
香港大学
301解放军总医院
东南大学
鼓楼医院
恒瑞
华中科技大学
集萃药康
江苏省疾病预防控制中心
江苏省人民医院
江苏省肿瘤医院
凯基生物
南京大学
南京正大天晴
赛赋医药
苏大附一医院
泰格医药
先声药业
昭衍
Honor
-
第一届江苏省信息消费大赛总决赛产品创新二等奖
-
中国创新创业大赛江苏赛区优秀企业
-
中国第一个进入空间站并实施科学实验的器官芯片
-
中国第一个器官芯片技术标准
-
中国第一个用于申请新药IND的器官芯片
©2023 Jiangsu Avatarget Biotechnology Co., Ltd. All rights reserved Website Construction:China Enterprise Power Kunshan SEO
We use optional cookies to improve your experience on our website, including through social media connections, and to personalize ads based on your online activity. If you refuse optional cookies, we will only use cookies that are necessary to provide you with the services.Privacy Statement
